Literature DB >> 12002721

Kidney failure after treatment with 90Y-DOTATOC.

Tilmann Schumacher, Christian Waldherr, Jan Mueller-Brand, Helmut Maecke.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 12002721     DOI： 10.1007/s00259-001-0720-2

Source DB:  PubMed          Journal:  Eur J Nucl Med Mol Imaging        ISSN： 1619-7070            Impact factor:   9.236


× No keyword cloud information.
  8 in total

1.  Between the Scylla and Charybdis of peptide radionuclide therapy: hitting the tumor and saving the kidney.

Authors:  O C Boerman; W J Oyen; F H Corstens
Journal:  Eur J Nucl Med       Date:  2001-10

2.  A new cause of renal thrombotic microangiopathy: yttrium 90-DOTATOC internal radiotherapy.

Authors:  S Moll; V Nickeleit; J Mueller-Brand; F P Brunner; H R Maecke; M J Mihatsch
Journal:  Am J Kidney Dis       Date:  2001-04       Impact factor: 8.860

3.  End-stage renal disease after treatment with 90Y-DOTATOC.

Authors:  M Cybulla; S M Weiner; A Otte
Journal:  Eur J Nucl Med       Date:  2001-10

4.  Yttrium-90 DOTATOC: first clinical results.

Authors:  A Otte; R Herrmann; A Heppeler; M Behe; E Jermann; P Powell; H R Maecke; J Muller
Journal:  Eur J Nucl Med       Date:  1999-11

Review 5.  Reducing the renal uptake of radiolabeled antibody fragments and peptides for diagnosis and therapy: present status, future prospects and limitations.

Authors:  T M Behr; D M Goldenberg; W Becker
Journal:  Eur J Nucl Med       Date:  1998-02

6.  D-lysine reduction of indium-111 octreotide and yttrium-90 octreotide renal uptake.

Authors:  B F Bernard; E P Krenning; W A Breeman; E J Rolleman; W H Bakker; T J Visser; H Mäcke; M de Jong
Journal:  J Nucl Med       Date:  1997-12       Impact factor: 10.057

7.  Reduction of the renal uptake of radiolabeled monoclonal antibody fragments by cationic amino acids and their derivatives.

Authors:  T M Behr; R M Sharkey; M E Juweid; R D Blumenthal; R M Dunn; G L Griffiths; H J Bair; F G Wolf; W S Becker; D M Goldenberg
Journal:  Cancer Res       Date:  1995-09-01       Impact factor: 12.701

8.  Amino acid infusion blocks renal tubular uptake of an indium-labelled somatostatin analogue.

Authors:  P J Hammond; A F Wade; M E Gwilliam; A M Peters; M J Myers; S G Gilbey; S R Bloom; J Calam
Journal:  Br J Cancer       Date:  1993-06       Impact factor: 7.640
  8 in total
  1 in total

1.  Guidelines for the management of gastroenteropancreatic neuroendocrine (including carcinoid) tumours.

Authors:  J K Ramage; A H G Davies; J Ardill; N Bax; M Caplin; A Grossman; R Hawkins; A M McNicol; N Reed; R Sutton; R Thakker; S Aylwin; D Breen; K Britton; K Buchanan; P Corrie; A Gillams; V Lewington; D McCance; K Meeran; A Watkinson
Journal:  Gut       Date:  2005-06       Impact factor: 23.059
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.